| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015 | 1410 | 2015 |
| Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial C Gridelli, F Perrone, C Gallo, S Cigolari, A Rossi, F Piantedosi, ... Journal of the National Cancer Institute 95 (5), 362-372, 2003 | 1077 | 2003 |
| Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer T Elderly Lung Cancer Vinorelbine Italian Study Group Journal of the National Cancer Institute 91 (1), 66-72, 1999 | 781 | 1999 |
| Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data A Rossi, M Di Maio, P Chiodini, RM Rudd, H Okamoto, DV Skarlos, ... Journal of Clinical Oncology 30 (14), 1692-1698, 2012 | 617 | 2012 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study D Lobo, JM Devys Anaesthesia 77 (1), 110, 2021 | 583* | 2021 |
| Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non—small-cell lung cancer receiving … P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ... Journal of Clinical Oncology 23 (28), 6865-6872, 2005 | 579 | 2005 |
| c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. C Carlomagno, F Perrone, C Gallo, M De Laurentiis, R Lauria, A Morabito, ... Journal of Clinical Oncology 14 (10), 2702-2708, 1996 | 574 | 1996 |
| Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials M Di Maio, C Gallo, NB Leighl, MC Piccirillo, G Daniele, F Nuzzo, ... Journal of Clinical oncology 33 (8), 910-915, 2015 | 506 | 2015 |
| A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators CLIP Group Hepatology 28, 751-755, 1998 | 466* | 1998 |
| Cells of the human intestinal tract mapped across space and time R Elmentaite, N Kumasaka, K Roberts, A Fleming, E Dann, HW King, ... Nature 597 (7875), 250-255, 2021 | 446 | 2021 |
| Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial S Pignata, G Scambia, D Katsaros, C Gallo, E Pujade-Lauraine, ... The Lancet Oncology 15 (4), 396-405, 2014 | 431 | 2014 |
| Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer N Normanno, M Di Maio, E De Maio, A De Luca, A de Matteis, A Giordano, ... Endocrine-related cancer 12 (4), 721-747, 2005 | 382 | 2005 |
| Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study G Colucci, R Labianca, F Di Costanzo, V Gebbia, G Cartenì, B Massidda, ... Journal of Clinical Oncology 28 (10), 1645-1651, 2010 | 381 | 2010 |
| Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions A Morabito, E De Maio, M Di Maio, N Normanno, F Perrone The oncologist 11 (7), 753-764, 2006 | 346 | 2006 |
| Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non–small-cell lung cancer: A phase III trial of the Italian … C Gridelli, C Gallo, FA Shepherd, A Illiano, F Piantedosi, SF Robbiati, ... Journal of Clinical Oncology 21 (16), 3025-3034, 2003 | 341 | 2003 |
| Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials M Di Maio, C Gridelli, C Gallo, F Shepherd, FV Piantedosi, S Cigolari, ... The lancet oncology 6 (9), 669-677, 2005 | 301 | 2005 |
| The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline M Di Maio, E Basch, F Denis, LJ Fallowfield, PA Ganz, D Howell, ... Annals of Oncology 33 (9), 878-892, 2022 | 290 | 2022 |
| Treatment of advanced non–small-cell lung cancer in the elderly: Results of an international expert panel C Gridelli, M Aapro, A Ardizzoni, L Balducci, F De Marinis, K Kelly, ... Journal of Clinical Oncology 23 (13), 3125-3137, 2005 | 283 | 2005 |
| First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non–small-cell lung cancer: the TORCH randomized trial C Gridelli, F Ciardiello, C Gallo, R Feld, C Butts, V Gebbia, P Maione, ... Journal of Clinical Oncology 30 (24), 3002-3011, 2012 | 278 | 2012 |
| Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial S Pignata, G Scambia, G Ferrandina, A Savarese, R Sorio, E Breda, ... Journal of clinical oncology 29 (27), 3628-3635, 2011 | 272 | 2011 |
